Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.

How to buy Neuronetics (STIM) stocks in Canada

Learn how to easily invest in Neuronetics stocks.

Neuronetics is a diagnostics & research business based in the US. Neuronetics stocks (STIM.US) are listed on the NASDAQ and all prices are listed in US Dollars. Its last market close was $14.57 – a decrease of 11.22% over the previous week. Neuronetics employs 165 staff and has a trailing 12-month revenue of around $55.9 million.

How to buy shares in Neuronetics

  1. Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
  2. Open your brokerage account. Complete an application with your details.
  3. Confirm your payment details. Fund your account.
  4. Research the stock. Find the stock by name or ticker symbol – STIM – and research it before deciding if it's a good investment for you.
  5. Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
  6. Check in on your investment. Optimize your portfolio by tracking your stock.

Neuronetics stock price (NASDAQ:STIM)

Use our graph to track the performance of STIM stocks over time.

Neuronetics shares at a glance

Information last updated 2022-01-17.
Latest market close$3.56
52-week range$3.64 - $22.43
50-day moving average $4.40
200-day moving average $9.13
Wall St. target price$10.33
PE ratio N/A
Dividend yield N/A (0%)
Earnings per share (TTM) $-1.15

Compare online stock trading platforms

Note: The dollar amounts in the table below are in Canadian dollars.

Name Product Finder Rating Stock Trading Fee Account Fee Available Asset Types Offer
FREE TRADES
Wealthsimple Trade
Finder Rating:
★★★★★
3.9 / 5
$0
$0
Stocks, ETFs
Get 2 free stocks when you deposit and trade $150.
Scotia iTRADE
Finder Rating:
★★★★★
3.8 / 5
$4.99 - $9.99
$0
Bonds, Options, Mutual Funds, ETFs, GICs, International Equities
Interactive Brokers
Finder Rating:
★★★★★
4.1 / 5
Min. $1.00, Max. 0.5%
$0
Stocks, Bonds, Options, ETFs, Currencies, Futures
OFFER
CIBC Investor's Edge
Finder Rating:
★★★★★
4 / 5
$4.95 - $6.95
$0 if conditions met, otherwise $100/year
Stocks, Bonds, Options, Mutual Funds, ETFs
Get up to $2,000 cash back. Conditions apply. Offer ends March 1, 2022.
Questrade
Finder Rating:
★★★★★
4.2 / 5
$4.95 - $9.95
$0
Stocks, Bonds, Options, Mutual Funds, ETFs, GICs, International Equities, Precious Metals
Get $50 in free trades when you fund your account with a minimum of $1,000.
Qtrade Direct Investing
Finder Rating:
★★★★★
4.1 / 5
$6.95 - $8.75
$0 if conditions met, otherwise $25/quarter
Stocks, Bonds, Options, Mutual Funds, ETFs, GICs
Get a $50 bonus when you open a new RRSP, TFSA or RESP and start pre-authorized contributions of $200+/month. Valid until March 1, 2022.
loading

Compare up to 4 providers

Online stock trading

Is it a good time to buy Neuronetics stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

Neuronetics price performance over time

Historical closes compared with the close of $3.56 from 2022-01-21

1 week (2022-01-14) -11.22%
1 month (2021-12-22) -20.54%
3 months (2021-10-22) -33.08%
6 months (2021-07-22) -73.71%
1 year (2021-01-22) -83.26%
2 years (2020-01-22) -17.02%
3 years (2019-01-22) 13.84
5 years (2017-01-18) N/A

Neuronetics financials

Revenue TTM $55.9 million
Gross profit TTM $37.7 million
Return on assets TTM -12.6%
Return on equity TTM -45.91%
Profit margin -48.71%
Book value $3.46
Market capitalisation $105.7 million

TTM: trailing 12 months

Neuronetics share dividends

We're not expecting Neuronetics to pay a dividend over the next 12 months.

Neuronetics share price volatility

Over the last 12 months, Neuronetics's shares have ranged in value from as little as $3.64 up to $22.43. A popular way to gauge a stock's volatility is its "beta".

STIM.US volatility(beta: 2.38)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Neuronetics's is 2.3763. This would suggest that Neuronetics's shares are significantly more volatile than the average for this exchange and represent a higher risk.

Neuronetics overview

Neuronetics, Inc. , a commercial stage medical technology company, designs, develops, and markets products for patients with psychiatric disorders in the United States and internationally. The company offers NeuroStar Advanced Therapy System, a non-invasive and non-systemic office-based treatment to treat adult patients with major depressive disorder. Its NeuroStar Advanced Therapy System uses transcranial magnetic stimulation to create a pulsed, MRI-strength magnetic field that induces electrical currents designed to stimulate specific areas of the brain associated with mood. The company sells its products through its sales and customer support team to psychiatrists. Neuronetics, Inc. was incorporated in 2003 and is headquartered in Malvern, Pennsylvania.

Frequently asked questions

Disclaimer: This information should not be interpreted as an endorsement of futures, stocks, ETFs, CFDs, options or any specific provider, service or offering. It should not be relied upon as investment advice or construed as providing recommendations of any kind. Futures, stocks, ETFs and options trading involves substantial risk of loss and therefore are not appropriate for all investors. Trading CFDs and forex on leverage comes with a higher risk of losing money rapidly. Past performance is not an indication of future results. Consider your own circumstances, and obtain your own advice, before making any trades.

More on investing

More guides on Finder

Go to site